CME Webcast Teaches on Preventive Cardiology

OSUWexnerbloglogo2014 CME Webcast Teaches on Preventive Cardiology. The best way to improve outcomes in cardiovascular disease is to not get it in the first place and today on MedNet21, we are going to show you what you can do to prevent heart disease in your patients. Let me welcome today’s guests. Dr. Wesley Milks is a cardiologist and Assistant Professor of Internal Medicine and Kelly Bartsch is a pharmacist specializing in lipid management.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW
the mechanisms of action of the major medication classes utilized in the 2018 multi-society cholesterol guidelines; and UNDERSTAND the influence of the new cardiovascular outcomes trials for ezetimibe and the PCSK9 inhibitors on the new cholesterol guidelines; DEMONSTRATE understanding of key atherosclerotic risk and risk-enhancing factors as well as of recent pivotal lipid lowering treatment guidelines; and SELECT the appropriate target of lipid lowering therapy (e.g. LDL-C or non-HDL-C) with respect to the patient’s comorbid metabolic conditions.

You’ll also learn about the following:

  • Cholesterol level goals
  • Indications for medical treatment of lipids
  • Follow-up of patients started on cholesterol lowering drugs
  • Monitoring of cholesterol lowering drugs
  • CRP and other inflammatory markers

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Advances in Liver Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Advances in Liver Disease on CME Webcast. On this CME webcast, we’re going to hear about the latest chapter in the hepatitis C saga, that is, the treatment of hepatitis C. And we’re also going to hear about some of the other emerging liver diseases that you are likely to encounter in your clinical practice and some of the tools hepatologists use to evaluate liver conditions. Let me welcome today’s guests, both hepatologists from the Ohio State University. Dr. James Hanje is an Associate Professor of Internal Medicine and Dr. Anthony Michaels is also an Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Recognize the change in patient population in patients with chronic liver disease; Describe the problem of frailty; Review
methods of Hepatitis C diagnosis and staging; and Review current therapeutic Hepatitis C treatment options.

You’ll also learn about the following:

  • Causes of liver disease in the United States
  • Hepatitis C
  • The economics of treating hepatitis C
  • Transmission of hepatitis C

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Update on Adult Congenital Heart Disease

OSUWexnerbloglogo2014 Update on Adult Congenital Heart Disease. On this CME webcast, we’re going to update you on some of the unique challenges of diagnosing and treating adults with congenital heart disease. Joining our moderator in the studio is cardiologist and Assistant Professor of Internal Medicine, Dr. Saurabh Rajpal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: INCREASE awareness about increasing prevalence of Adult Congenital Heart disease; and DISCUSS common congenital
heart disease diagnoses encountered in adult practice.

You’ll also learn about the following:

  • Common causes of congenital heart disease in adult patients
  • Changing prevalence of congenital heart disease in adults
  • Follow up testing and monitoring
  • Marfan syndrome

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Common Spine Disorders On CME Webcast

OSUWexnerbloglogo2014 Learn About Common Spine Disorders On CME Webcast. The most recent hurdle of impossibility was the application of minimally invasive techniques to spine surgery and these techniques now allow surgeons to repair the spine with less tissue disruption than ever before. Let’s welcome our guests today who are going to bring us up to date on new developments in spine surgery, Dr. Andrew Grossbach is Assistant Professor of Neurological Surgery and Dr. Stephanus Viljoen is also an Assistant Professor of Neurological Surgery, both from the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE what conditions can be treated with MIS spine surgery; and UNDERSTAND What to look for with cervical myelopathy.

You’ll also learn about the following:

  • Minimally invasive techniques in spine surgery
  • Cervical spondylotic myelopathy
  • Equipment used in minimally invasive spine surgery
  • Post-op recovery and long-term outcomes
  • Symptoms of Cervical Spondylotic myelopathy
  • Imaging strategies for cervical spine conditions
  • Imaging strategies for thoracic and lumbar spine conditions
  • Red flags on the CT or MRI report
  • Post-op recommendations after cervical spine surgery
  • Prevention of cervical spondylotic myelopathy

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Treatment of Opioid Dependency on CME Webcast

OSUWexnerbloglogo2014 Learn About Treatment of Opioid Dependency on CME Webcast. In the 55 years since Dr. Dole began his ground breaking research in the treatment of opioid addiction, we have come a long way toward better understanding the effects of opioids and toward developing effective treatment for opioid addiction. However all of these advances have been eclipsed by increased opioid use in the United States fueled by the unbridled prescription of opioid pain relievers in the 1990’s and 2000’s, by price reduction in heroin on the streets, and by recent availability of newer high potency opioids such as fentanyl. But there is hope and on this CME webcast, we’re going to hear about some of the effective solutions to opioid addiction. Here with me in the studio is addiction specialist and Assistant Professor of Psychiatry, Dr. Casia Horseman.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the assessment of opioid use disorder; and DESCRIBE pharmacological and psychosocial treatments for opioid use disorder.

You’ll also learn about the following:

  • Demographics of opioid addiction
  • Why opioid use is such a growing problem
  • Why patients relapse
  • Treatment selection strategies
  • The role of the primary care physician in the treatment of opioid use disorder
  • Insurance coverage for treatment
  • Time-limited opioid prescriptions to relieve withdrawal symptoms
  • Inpatient management of the patient already on medication treatment for opioid addiction

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.